No insider purchase over the last 90 days. The latest, by Zhou Xuhua, was filed 25 Nov 2025.
This page follows insider dealings at Kingworld Medicines Group Ltd. as filed with HKEX. 5 insiders have disclosed 5 filings since 19 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 5 purchases, made by 5 insiders. The amount is not disclosed for 5 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 5 senior executives among the declarants.
Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark. Since 2017, the database holds 113 purchases and 1 sale by insiders of the company.
The last purchase on record was published on 25 November 2025, which is 330 days ago. Filings reach the HKEX feed a median of 3 days after the trade. That lag is the time during which only the insider knows about the trade.
For comparison within the same market, see the insider buying recorded at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 114 declarations
Purchases our model currently ranks for the recommendations list.
All recommendations